Stock AFMD AFFIMED N.V.
Add to a list
To use this feature you must be a member
Log inSign up

Sector Chart Affimed N.V.

Equities

AFMD

NL0015001ZQ0

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-05-24 pm EDT 		5-day change 1st Jan Change
4.19 USD -11.04% Intraday chart for Affimed N.V. -20.19% -32.96%
May. 23 Affimed Announces Positive Early Efficacy and Progression Free Survival Results of AFM24-102 Study in EGFR Wild-Type Non-Small Cell Lung Cancer at the Annual Meeting of the American Society of Clinical Oncology 2024 CI
Apr. 01 Wells Fargo Cuts Affimed Price Target to $25 From $30, Maintains Overweight Rating MT
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Bio Therapeutic Drugs

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
AFFIMED N.V. Stock Affimed N.V.
 63.8M - - -
VERTEX PHARMACEUTICALS INCORPORATED Stock Vertex Pharmaceuticals Incorporated
 118B
REGENERON PHARMACEUTICALS, INC. Stock Regeneron Pharmaceuticals, Inc.
 106B
BIONTECH SE Stock BioNTech SE
 23.4B -
ARGENX SE Stock argenx SE
 21.78B -
GENMAB A/S Stock Genmab A/S
 18.09B
  1. Stock Market
  2. Equities
  3. AFMD Stock
  4. Charts Affimed N.V.
  5. Sector Chart